MB, Levis & Associates’s Corteva CTVA Stock Holding History

MB, Levis & Associates’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.8K	Buy	553 +2	+0.4%	+$161	0.02%	109
2026 Q1	$46.2K	Buy	551 +1	+0.2%	+$75	0.02%	105
2025 Q4	$36.9K	Buy	550 +1	+0.2%	+$65	0.02%	115
2025 Q3	$37.1K	Buy	549 +1	+0.2%	+$72	0.02%	113
2025 Q2	$40.8K	Buy	548 +2	+0.4%	+$133	0.02%	133
2025 Q1	$34.4K	Buy	546 +1	+0.2%	+$62	0.02%	142
2024 Q4	$31K	Buy	545 +2	+0.4%	+$118	0.02%	141
2024 Q3	$31.9K	Buy	543 +1	+0.2%	+$55	0.02%	141
2024 Q2	$29.2K	Buy	542 +2	+0.4%	+$110	0.02%	141
2024 Q1	$31.2K	Buy	540 +1	+0.2%	+$52	0.02%	139
2023 Q4	$25.8K	Buy	539 +2	+0.4%	+$95	0.01%	144
2023 Q3	$27.5K	Buy	537 +1	+0.2%	+$53	0.02%	140
2023 Q2	$30.7K	Buy	536 +2	+0.4%	+$117	0.02%	141
2023 Q1	$32.2K	Buy	534 +1	+0.2%	+$61	0.02%	138
2022 Q4	$31.3K	Buy	+533	New	+$33.7K	0.02%	126

Other funds holding CTVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

MB, Levis & Associates's CTVA Position: Q2 2026 in Review

MB, Levis & Associates increased its Corteva (CTVA) stake by 0.36% in Q2 2026, buying an estimated $161 and bringing the position to 553 shares worth $46.8K. The position accounts for 0.02% of the portfolio, ranked #109.

MB, Levis & Associates first reported a position in CTVA in Q4 2022 and has held it in 15 quarters since. 1,487 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

MB, Levis & Associates held 553 shares of Corteva worth $46.8K as of Q2 2026.
MB, Levis & Associates bought 2 Corteva shares in Q2 2026, an estimated $161.
Corteva made up 0.02% of MB, Levis & Associates's portfolio in Q2 2026, its #109 holding.
MB, Levis & Associates first reported a position in Corteva in Q4 2022 and has held it in 15 quarters since.
1,487 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.